Cellular and Molecular Neurobiology, 2023 · DOI: https://doi.org/10.1007/s10571-022-01229-0 · Published: May 23, 2022
This review examines the role of tumor necrosis factor (TNF) after spinal cord injury (SCI), focusing on its impact on inflammation and potential as a therapeutic target. SCI triggers an inflammatory response, with TNF playing a central role. The review analyzes TNF's expression, cellular sources, and the effects of TNF manipulation on SCI outcomes. The findings suggest TNF inhibition could be a promising therapeutic option for SCI, but the complexity of TNF's role requires careful consideration of timing and specificity in treatment strategies.
Targeting TNF signaling after SCI could be a useful therapeutic approach.
TNF levels could serve as a biomarker for assessing the severity and prognosis of SCI.
Age-related differences in TNF expression suggest the need for personalized therapeutic strategies.